Analysis of Amino Acid Variants in Malignant Melanoma Cells Resistant to BRAF inhibition
M. Schmitt, T. Sinnberg, K. Bratl, K. Zittlau, C. Garbe, B. Macek, N. C. Nalpas
The paper uses proteogenomics to analyze amino acid variants in BRAF inhibitor-resistant melanoma cells, identifying PTM changes and predicting effective therapies.
bioRxiv · Dec 15, 2020 · PreprintCancer Biology